Advancing Care in Recurrent Low-Grade Serous
Ovarian Cancer, a Case Based Approach
Industry Supported Symposium

Activity Overview

The GOG Foundation, Inc. and GOG Partners welcome gynecologic oncologists, oncologists, advanced practitioners (NP/PA/PharmD), and other clinicians who treat patients with gynecologic malignancies to view the Advancing Care in Recurrent Low-Grade Serous Ovarian Cancer, A Case Based Approach Industry Supported Symposium presented at the 2025 SGO Annual Meeting on Women’s Cancer® on Monday, March 17, 2025.

This session will explore the evolving treatment landscape of frontline and recurrent low-grade serous ovarian cancer (LGSOC), with primary focus on recurrent LGSOC, a distinct subtype of ovarian cancer that presents challenges in clinical management. The session will provide attendees with expert insights into recent clinical data, focusing on innovative therapies, combination treatment regimens, and emerging clinical trial results. By expanding the treatment options and improving therapeutic outcomes, we aim to maximize patient survival and quality of life. Attendees will gain a deeper understanding of current and future treatment strategies, with an emphasis on making informed decisions that can lead to more personalized care for patients with recurrent LGSOC.

Target Audience

This symposium is designed for gynecologic oncologists, medical oncologists, researchers, clinical trial coordinators, and healthcare professionals involved in the treatment and management of ovarian cancer, as well as those interested in the latest advancements in cancer therapies.

Learning Objectives

Upon completion of the activities in this series, learners will demonstrate increased knowledge regarding:

  • Describe the challenges in managing recurrent low-grade serous ovarian cancer (LGSOC) and understand the clinical complexities associated with this disease.
  • Summarize the most recent clinical trial data and treatment options for recurrent LGSOC, with a focus on novel therapies and combination treatment strategies.
  • Discuss best practices for clinical management and outline potential future directions in the treatment of recurrent LGSOC

Agenda

Advancing Care in Recurrent Low-Grade Serous Ovarian Cancer, a Case Based Approach, an Industry Supported Symposium presented at the 2025 SGO Annual Meeting on Women’s Cancer®

 

Presented on Monday, March 17, 2025

This enduring education will be available on the GOG website for six months after the live presentation.

View Recording

View Presentation

Welcome & Introductions
Brian Slomovitz, MD, FACOG
Current Clinical Landscape of First-Line Therapy for Newly Diagnosed LGSOC
David M. Gershenson, MD
Case 1: Incorporating Best Available Approaches in the Management of LGSOC
Isabelle Ray-Coquard, MD, PhD
Case 2: Incorporating Best Investigational Strategies in the Management of LGSOC
Rachel N. Grisham, MD
Closing Remarks
Brian Slomovitz, MD, FACOG